Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02676128 · ClinicalTrials.gov registry record · NA

Mobile Health Application to Improve HIV Medication Adherence

A NA study of HIV and Medication Adherence, sponsored by Rhode Island Hospital.

Completed
Registry status
NA
Development phase
80
Enrollment target
1
Study location

NCT02676128: Completed NA study of HIV and Medication Adherence, sponsored by Rhode Island Hospital.

NCT02676128 is a NA study of HIV and Medication Adherence that has completed, run by Rhode Island Hospital. The registered enrollment target is 80 participants, below the 440-participant average among 303 other HIV trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02676128, a NA study of HIV and Medication Adherence, has completed, sponsored by Rhode Island Hospital.

COMPLETED
Registry status
NA
Development phase
80 participants
Enrollment target
1
Study location

Study Summary

Inadequate adherence to antiretroviral therapy (ART) can impede successful viral suppression and consequently lead to negative health consequences. This study aims to refine and test the efficacy of a mobile health ART adherence application (ARTAA), delivered over a smartphone, with helping individuals improve their ART adherence.

Primary Outcome

Percentage of ART adherence based on Electronic Pill Box data will be compared between the groups

Interventions

  • BEHAVIORAL Twine Collaborative Care Application
  • BEHAVIORAL Information-Motivation-Behavioral Skills Model of ART Adherence

Study Locations (1)

Rhode Island

  • Rhode Island Hospital - Providence

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2016-03
Est. Completion 2020-05
Phase NA
Rhode Island Hospital

130 total trials

What the finished NCT02676128 record still lists

NCT02676128 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 440-participant average among 303 other HIV trials with a reported enrollment target (82% lower).

The record links to 3 conditions, with HIV appearing as the primary indexed condition, and to 2 interventions - of which Twine Collaborative Care Application is the first listed.

NCT02676128 reports a single indexed study location in Rhode Island.

Frequently Asked Questions

What is clinical trial NCT02676128 about?

NCT02676128 is a clinical study titled "Mobile Health Application to Improve HIV Medication Adherence". Inadequate adherence to antiretroviral therapy (ART) can impede successful viral suppression and consequently lead to negative health consequences. This study aims to refine and test the efficacy of a mobile health ART adherence application (ARTAA), delivered over a smartphone, with helping individu...

What is the current status of trial NCT02676128?

This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2016-03. Estimated completion is 2020-05.

What conditions does trial NCT02676128 study?

This clinical trial studies the following conditions: HIV, Medication Adherence, Mobile Health.

What interventions are being tested in trial NCT02676128?

The interventions under investigation include: Twine Collaborative Care Application (BEHAVIORAL), Information-Motivation-Behavioral Skills Model of ART Adherence (BEHAVIORAL).

Who is sponsoring clinical trial NCT02676128?

This trial is sponsored by Rhode Island Hospital, which has 130 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02676128 being conducted?

This trial has 1 study location across Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for HIV

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02676128's enrollment target sits among peer trials

80 175th of 303 higher than 124 of 303 other HIV trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other HIV trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01243931 · 80 participants · NA

    Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy

  • NCT01659203 · 80 participants · Phase 1

    Proton or Photon RT for Retroperitoneal Sarcomas

  • NCT01803451 · 80 participants · Early Phase 1

    Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass

  • NCT01964859 · 80 participants · Phase 2

    Feasibility Study for Fibroblast Autologous Skin Grafts

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02676128, the US trial registry maintained by the National Library of Medicine. NCT02676128 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.